Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sorbic International was a leading producer of sorbic acid and potassium sorbate, which are widely used as high-end food preservatives and pharmaceutical excipients. Based in China and formerly listed on the London Stock Exchange's AIM market, the company operated through its primary subsidiary, Linyi City Hongda Industry. Its products were essential for extending the shelf life of various consumer goods by inhibiting the growth of molds, yeasts, and fungi. The company served a global market, providing high-purity chemicals required for both the food and beverage and pharmaceutical industries. However, the company faced significant corporate governance challenges and financial difficulties, leading to its delisting in 2014. At its peak, it was recognized as one of the largest manufacturers of sorbic acid products in the world.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sorbic International.